Innovative Approaches for Monitoring Cardiotoxicity 2012

Drug-induced adverse events account for most drug recalls and delays experienced in gaining regulatory approvals. While improvements in pre-clinical screening and clinical trial design have helped with better detection and monitoring of such adverse events, the problem still persists and often goes unnoticed until the compound is further along in development and testing. Cambridge Healthtech Institute’s Fifth Annual Predicting Drug-Induced Cardiotoxicity conference and the Fourth Annual Tackling Drug-Induced Idiosyncratic Hepatotoxicity conference focuses on innovative strategies for predicting drug-induced organ toxicities. The two co-located conferences will bring together leading experts in drug safety to discuss the use of in vitro, in vivo and in silico tools for early prediction and detection of drug-induced adverse events.